Gautam Sanyal | Principal Consultant
Vaccine Analytics, LLC, USA

Afer receiving his Ph.D. in Chemistry from the University of Virginia, USA, Gautam held academic faculty 
positions at the University of Florida, Mayo Clinic and Hamilton College before moving to pharmaceutical 
industry. During the 27 years that Gautam spent in pharmaceutical industry, he headed R&D departments 
and groups at Merck, AstraZeneca and MedImmune (AstraZeneca Biopharmaceuticals). For the past 
several years, Gautam has focused his efforts on global health initiatives. He is a CMC Subject Matter 
Expert with the Gates Foundation and has been associated with other global health organizations such as 
CEPI, PATH and the International Vaccine Institute. 
Gautam is a scientific expert in development of analytical and biophysical methods that are essential to 
batch release and characterization of vaccines and biopharmaceuticals. His expertise extends to rational 
formulation design, as demonstrated by delivery of several safe and effective formulations to clinical trials 
for recombinant protein based VLPs and attenuated viral vaccines as well as therapeutic proteins and 
oncolytic viruses. More recently, Gautam has been involved in advisory roles on projects emerging from 
the newer vaccine technologies, with a focus on analytical characterization and assays for mRNA vaccines. 
Apart from his extensive work on vaccines and biologics, Gautam led biochemistry, biophysics and protein 
science teams in target-based discovery of antibacterial therapeutics. He has an extensive record of highly 
cited publications including original research papers, review articles and book chapters.